114 related articles for article (PubMed ID: 20682340)
1. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.
Soneson C; Fontes M; Zhou Y; Denisov V; Paulsen JS; Kirik D; Petersén A;
Neurobiol Dis; 2010 Dec; 40(3):531-43. PubMed ID: 20682340
[TBL] [Abstract][Full Text] [Related]
2. Volumetric analysis of the hypothalamus in Huntington Disease using 3T MRI: the IMAGE-HD Study.
Gabery S; Georgiou-Karistianis N; Lundh SH; Cheong RY; Churchyard A; Chua P; Stout JC; Egan GF; Kirik D; Petersén Å
PLoS One; 2015; 10(2):e0117593. PubMed ID: 25659157
[TBL] [Abstract][Full Text] [Related]
3. Concurrent Cross-Sectional and Longitudinal Analyses of Multivariate White Matter Profiles and Clinical Functioning in Pre-Diagnosis Huntington Disease.
Ciarochi JA; Johnson HJ; Calhoun VD; Liu J; Espinoza FA; Bockholt HJ; Misiura M; Caprihan A; Plis S; Paulsen JS; Turner JA;
J Huntingtons Dis; 2019; 8(2):199-219. PubMed ID: 30932891
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study.
Reed ER; Latourelle JC; Bockholt JH; Bregu J; Smock J; Paulsen JS; Myers RH;
Neurology; 2018 Jan; 90(4):e264-e272. PubMed ID: 29282329
[TBL] [Abstract][Full Text] [Related]
5. Assessment of motor symptoms and functional impact in prodromal and early huntington disease.
Vaccarino AL; Sills T; Anderson KE; Biglan K; Borowsky B; Giuliano J; Guttman M; Ho AK; Kennard C; Kupchak P; Landwehrmeyer GB; Michell A; Paulsen JS; Reilmann R; van Kammen DP; Warner JH; Evans K
PLoS Curr; 2011 Jun; 2():RRN1244. PubMed ID: 21804956
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal Fluid Flow in Patients with Huntington's Disease.
Hett K; Eisma JJ; Hernandez AB; McKnight CD; Song A; Elenberger J; Considine C; Donahue MJ; Claassen DO
Ann Neurol; 2023 Nov; 94(5):885-894. PubMed ID: 37493342
[TBL] [Abstract][Full Text] [Related]
7. Microarray profiling of hypothalamic gene expression changes in Huntington's disease mouse models.
Dickson E; Dwijesha AS; Andersson N; Lundh S; Björkqvist M; Petersén Å; Soylu-Kucharz R
Front Neurosci; 2022; 16():1027269. PubMed ID: 36408416
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia.
Bergh S; Cheong RY; Petersén Å; Gabery S
Front Mol Neurosci; 2022; 15():984317. PubMed ID: 36187357
[TBL] [Abstract][Full Text] [Related]
9. Hsp40 overexpression in pacemaker neurons delays circadian dysfunction in a Drosophila model of Huntington's disease.
Prakash P; Pradhan AK; Sheeba V
Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35645202
[TBL] [Abstract][Full Text] [Related]
10. IKKβ signaling mediates metabolic changes in the hypothalamus of a Huntington disease mouse model.
Soylu-Kucharz R; Khoshnan A; Petersén Å
iScience; 2022 Feb; 25(2):103771. PubMed ID: 35146388
[TBL] [Abstract][Full Text] [Related]
11. Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington's disease.
Cruickshank T; Porter T; Laws SM; Ziman M; Bartlett DM
Sci Rep; 2021 Mar; 11(1):5464. PubMed ID: 33750863
[TBL] [Abstract][Full Text] [Related]
12. Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model.
Cheong RY; Baldo B; Sajjad MU; Kirik D; Petersén Å
Neuropathol Appl Neurobiol; 2021 Jun; 47(4):564-578. PubMed ID: 33330988
[TBL] [Abstract][Full Text] [Related]
13. Altered cerebrovascular response to acute exercise in patients with Huntington's disease.
Steventon JJ; Furby H; Ralph J; O'Callaghan P; Rosser AE; Wise RG; Busse M; Murphy K
Brain Commun; 2020; 2(1):fcaa044. PubMed ID: 32566927
[TBL] [Abstract][Full Text] [Related]
14. The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.
Quntanilla RA; Tapia-Monsalves C
Curr Neuropharmacol; 2020; 18(11):1076-1091. PubMed ID: 32448104
[TBL] [Abstract][Full Text] [Related]
15. The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.
Cheong RY; Gabery S; Petersén Å
J Huntingtons Dis; 2019; 8(4):375-391. PubMed ID: 31594240
[TBL] [Abstract][Full Text] [Related]
16. Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease.
Bartlett DM; Domínguez D JF; Reyes A; Zaenker P; Feindel KW; Newton RU; Hannan AJ; Slater JA; Eastwood PR; Lazar AS; Ziman M; Cruickshank T
Neurobiol Sleep Circadian Rhythms; 2019 Jan; 6():1-8. PubMed ID: 31236517
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging of Sleep Disturbances in Movement Disorders.
Yousaf T; Pagano G; Wilson H; Politis M
Front Neurol; 2018; 9():767. PubMed ID: 30323786
[TBL] [Abstract][Full Text] [Related]
18. Social Cognition and Oxytocin in Huntington's Disease: New Insights.
Unti E; Mazzucchi S; Frosini D; Pagni C; Tognoni G; Palego L; Betti L; Miraglia F; Giannaccini G; Ceravolo R
Brain Sci; 2018 Aug; 8(9):. PubMed ID: 30149684
[TBL] [Abstract][Full Text] [Related]
19. Regional Diversity in the Postsynaptic Proteome of the Mouse Brain.
Roy M; Sorokina O; McLean C; Tapia-González S; DeFelipe J; Armstrong JD; Grant SGN
Proteomes; 2018 Aug; 6(3):. PubMed ID: 30071621
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism.
Vercruysse P; Vieau D; Blum D; Petersén Å; Dupuis L
Front Mol Neurosci; 2018; 11():2. PubMed ID: 29403354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
